Evidence map›Paper›PMID 33803239›Full record

ArticleInternational journal of molecular sciences2021

Anti-Apoptotic Effect of Apelin in Human Placenta: Studies on BeWo Cells and Villous Explants from Third-Trimester Human Pregnancy.

Ewa Mlyczyńska, Małgorzata Myszka, Patrycja Kurowska, Monika Dawid, Tomasz Milewicz, Marta Bałajewicz-Nowak, Paweł Kowalczyk, Agnieszka Rak

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The Apelinergic System in Pregnancy.International journal of molecular sciences · 2023
    Review
  8. Article
  9. Review
  10. Review
  11. Lactoferrin as a Human Genome "Guardian"-An Overall Point of View.International journal of molecular sciences · 2022
    Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Amidation-Modified Apelin-13 Regulates PPARBioinorganic chemistry and applications · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ewa MlyczyńskaLaboratory of Physiology and Toxicology of Reproduction, Institute of Zoology and Biomedical Research, Jagiellonian University in Krakow, 30-387 Krakow, Poland.
Małgorzata MyszkaLaboratory of Physiology and Toxicology of Reproduction, Institute of Zoology and Biomedical Research, Jagiellonian University in Krakow, 30-387 Krakow, Poland.
Patrycja KurowskaLaboratory of Physiology and Toxicology of Reproduction, Institute of Zoology and Biomedical Research, Jagiellonian University in Krakow, 30-387 Krakow, Poland.
Monika DawidLaboratory of Physiology and Toxicology of Reproduction, Institute of Zoology and Biomedical Research, Jagiellonian University in Krakow, 30-387 Krakow, Poland.
Tomasz MilewiczDepartment of Gynecological Endocrinology, Jagiellonian University Medical College, 31-501 Krakow, Poland.
Marta Bałajewicz-NowakDepartment of Gynecology and Oncology, Jagiellonian University Medical College, 30-688 Krakow, Poland.ORCID 0000-0002-4988-464X
Paweł KowalczykDepartment of Animal Nutrition, The Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Science, 05-110 Jabłonna, Poland.
Agnieszka RakLaboratory of Physiology and Toxicology of Reproduction, Institute of Zoology and Biomedical Research, Jagiellonian University in Krakow, 30-387 Krakow, Poland.ORCID 0000-0002-9572-7151
Jagiellonian University · PLKielanowski Institute of Animal Physiology and Nutrition · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previously, we demonstrated the expression of apelin and G-protein-coupled receptor APJ in human placenta cell lines as well as its direct action on placenta cell proliferation and endocrinology. The objective of this study was to examine the effect of apelin on placenta apoptosis in BeWo cells and villous explants from the human third trimester of pregnancy. The BeWo cells and villous explants were incubated with apelin (2 and 20 ng/mL) alone or with staurosporine for 24 to 72 h. First, we analysed the dose- and time-dependent effect of apelin on the expression of apoptotic factors on the mRNA level by real-time PCR and on the protein level using Western blot. Next, we checked caspase 3 and 7 activity by Caspase-Glo 3/7, DNA fragmentation by the Cell Death Detection ELISA kit and oxygen consumption by the MitoXpress-Xtra Oxygen Consumption assay. We found that apelin increased the expression of pro-survival and decreased proapoptotic factors on mRNA and protein levels in both BeWo cells and villous explants. Additionally, apelin inhibited caspase 3 and 7 activity and DNA fragmentation in staurosporine-induced apoptosis as also attenuated oxidative stress by increasing extracellular oxygen consumption. The antiapoptotic effect of apelin in BeWo cells was mediated by the APJ receptor and mitogen-activated protein kinase (ERK1/2/MAP3/1) and protein kinase B (AKT). The obtained results showed the antiapoptotic effect of apelin on trophoblast cells, suggesting its participation in the development of the placenta.

Indexed as

Pregnancy Trimester, ThirdApelinApoptosisCaspase 3Caspase 7Cell Line, TumorExtracellular Signal-Regulated MAP KinasesFemaleHumansMAP Kinase Signaling SystemPlacentaPregnancyPregnancy ProteinsApelinCASP3 protein, humanCASP7 protein, humanCaspase 3Caspase 7Extracellular Signal-Regulated MAP KinasesPregnancy Proteinsapelinapoptosisoxidative stressplacentavillous explants

Identifiers

PMID33803239
PMCPMC7967155
OpenAlexW3135493134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.